325 related articles for article (PubMed ID: 8570211)
21. Human betacellulin structure modeled from other members of EGF family.
López-Torrejón I; Querol E; Avilés FX; Seno M; de Llorens R; Oliva B
J Mol Model; 2002 Apr; 8(4):131-44. PubMed ID: 12111392
[TBL] [Abstract][Full Text] [Related]
22. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen.
Huotari MA; Palgi J; Otonkoski T
Endocrinology; 1998 Apr; 139(4):1494-9. PubMed ID: 9528926
[TBL] [Abstract][Full Text] [Related]
23. Betacellulin-Pseudomonas toxin fusion proteins bind but are not cytotoxic to cells expressing HER4; correlation of EGFR for cytotoxic activity.
Mixan B; Cohen BD; Bacus SS; Fell HP; Siegall CB
Oncogene; 1998 Mar; 16(9):1209-15. PubMed ID: 9528863
[TBL] [Abstract][Full Text] [Related]
24. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
25. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
26. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
27. Heregulin-dependent translocation and hyperphosphorylation of ErbB-2.
Zhou W; Carpenter G
Oncogene; 2001 Jun; 20(29):3918-20. PubMed ID: 11439355
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of EGFR family-mediated HRG signals in human ovarian cancer.
Campiglio M; Ali S; Knyazev PG; Ullrich A
J Cell Biochem; 1999 Jun; 73(4):522-32. PubMed ID: 10733345
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
30. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells.
Mincione G; Piccirelli A; Lazzereschi D; Salomon DS; Colletta G
J Cell Physiol; 1998 Aug; 176(2):383-91. PubMed ID: 9648926
[TBL] [Abstract][Full Text] [Related]
31. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
Yang D; Kuan CT; Payne J; Kihara A; Murray A; Wang LM; Alimandi M; Pierce JH; Pastan I; Lippman ME
Clin Cancer Res; 1998 Apr; 4(4):993-1004. PubMed ID: 9563895
[TBL] [Abstract][Full Text] [Related]
32. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.
Wang LM; Kuo A; Alimandi M; Veri MC; Lee CC; Kapoor V; Ellmore N; Chen XH; Pierce JH
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6809-14. PubMed ID: 9618494
[TBL] [Abstract][Full Text] [Related]
33. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
34. Solution structure of betacellulin, a new member of EGF-family ligands.
Miura K; Doura H; Aizawa T; Tada H; Seno M; Yamada H; Kawano K
Biochem Biophys Res Commun; 2002 Jun; 294(5):1040-6. PubMed ID: 12074582
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies to the EGF receptor act as betacellulin antagonists.
Modjtahedi H; Dean C
Biochem Biophys Res Commun; 1996 Apr; 221(3):625-30. PubMed ID: 8630011
[TBL] [Abstract][Full Text] [Related]
36. The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer.
McIntyre E; Blackburn E; Brown PJ; Johnson CG; Gullick WJ
Breast Cancer Res Treat; 2010 Jul; 122(1):105-10. PubMed ID: 19760033
[TBL] [Abstract][Full Text] [Related]
37. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
Karunagaran D; Tzahar E; Beerli RR; Chen X; Graus-Porta D; Ratzkin BJ; Seger R; Hynes NE; Yarden Y
EMBO J; 1996 Jan; 15(2):254-64. PubMed ID: 8617201
[TBL] [Abstract][Full Text] [Related]
38. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.
Plowman GD; Green JM; Culouscou JM; Carlton GW; Rothwell VM; Buckley S
Nature; 1993 Dec; 366(6454):473-5. PubMed ID: 7902537
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.
Beerli RR; Hynes NE
J Biol Chem; 1996 Mar; 271(11):6071-6. PubMed ID: 8626392
[TBL] [Abstract][Full Text] [Related]
40. ErbB-4 ribozymes abolish neuregulin-induced mitogenesis.
Tang CK; Goldstein DJ; Payne J; Czubayko F; Alimandi M; Wang LM; Pierce JH; Lippman ME
Cancer Res; 1998 Aug; 58(15):3415-22. PubMed ID: 9699674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
